Celebrating the End of Cancer Treatment
Stefanie Joho, 25, had been given a death sentence. Diagnosed with advanced colon cancer, she traveled to cancer centers around the U.S. in search of… Read More »Celebrating the End of Cancer Treatment
Stefanie Joho, 25, had been given a death sentence. Diagnosed with advanced colon cancer, she traveled to cancer centers around the U.S. in search of… Read More »Celebrating the End of Cancer Treatment
Julie Brahmer, M.D., director of the Thoracic Oncology Program, began treating patients with immunotherapy drugs nearly a decade ago. She led one of the first… Read More »Side effects of immunotherapy: what to look for and when?
Immunotherapy expert, Suzanne Topalian, M.D., delivered a presentation to a standing room only crowd at the 2016 American Society of Clinical Oncology (#ASCO16) regarding new… Read More »Can biomarkers predict patients’ response to immunotherapy?
At the 2016 American Association for Cancer Research annual meeting today, scientists presented their results of a follow-up study tracking the survival of metastatic melanoma… Read More »One-third of patients with metastatic melanoma treated with immunotherapy drug nivolumab survive five years
Vice President Joe Biden spoke to researchers, medical students, government leaders and others during the dedication of the new Bloomberg~Kimmel Institute for Cancer Immunotherapy. It… Read More »Vice President Biden Speaks at Launch of Bloomberg~Kimmel Institute for Cancer Immunotherapy
On Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H.… Read More »A Conversation about Cancer
In today’s news, former President Jimmy Carter, who has metastatic melanoma, revealed that he has responded well to treatment. We asked melanoma expert Evan J.… Read More »Jimmy Carter Announces Cancer Scan Findings
There is good news today for lung cancer patients. The FDA has announced that it has approved expansion of the immunotherapy drug nivolumab (Opdivo) for… Read More »Immunotherapy drug approved for lung cancer
What better way to begin 2015 than with a nod to our scientists who, according to the American Society of Clinical Oncology (ASCO), have led… Read More »ASCO’s Best of 2014